Engineers Gate Manager LP Takes $1.87 Million Position in Haleon PLC Sponsored ADR $HLN

Key Points

• Engineers Gate Manager LP acquired 200,344 Haleon shares during the second quarter, valued at approximately $1.87 million. Several other institutional investors also increased their positions, though institutional ownership remains relatively low at 6.67%.
• Analyst sentiment is generally positive, with Haleon holding a consensus “Moderate Buy” rating. Ratings include two Strong Buys, two Buys, four Holds and one Sell.
• Haleon shares opened at $9.23, below their 50-day and 200-day moving averages, and trade within a 12-month range of $8.65 to $11.28. The company declared a $0.0642-per-share dividend, with a reported 30.77% payout ratio.

Engineers Gate Manager LP acquired a new position in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 200,344 shares of the company's stock, valued at approximately $1,869,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. NorthRock Partners LLC increased its holdings in shares of Haleon by 31.5% in the second quarter. NorthRock Partners LLC now owns 52,244 shares of the company's stock valued at $487,000 after buying an additional 12,500 shares in the last quarter. Integrated Wealth Concepts LLC boosted its stake in shares of Haleon by 48.9% during the 2nd quarter. Integrated Wealth Concepts LLC now owns 17,170 shares of the company's stock worth $160,000 after acquiring an additional 5,636 shares in the last quarter. NewEdge Advisors LLC grew its holdings in shares of Haleon by 19.4% in the 2nd quarter. NewEdge Advisors LLC now owns 133,508 shares of the company's stock worth $1,246,000 after acquiring an additional 21,693 shares during the last quarter. Squarepoint Ops LLC acquired a new position in shares of Haleon in the 2nd quarter worth $1,186,000. Finally, West Family Investments Inc. raised its position in shares of Haleon by 37.5% during the second quarter. West Family Investments Inc. now owns 18,226 shares of the company's stock worth $170,000 after purchasing an additional 4,966 shares during the period. 6.67% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HLN has been the subject of several analyst reports. Morgan Stanley reaffirmed an "overweight" rating on shares of Haleon in a report on Thursday, August 6th. Wall Street Zen raised Haleon from a "hold" rating to a "buy" rating in a research note on Sunday, July 12th. Rothschild & Co Redburn downgraded Haleon from a "strong-buy" rating to a "hold" rating in a report on Tuesday, June 16th. Zacks Research raised shares of Haleon from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 19th. Finally, Royal Bank Of Canada reiterated a "sector perform" rating on shares of Haleon in a report on Tuesday, August 11th. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy".

Haleon Price Performance

Shares of NYSE:HLN opened at $9.23 on Wednesday. The company's fifty day moving average is $9.84 and its two-hundred day moving average is $9.66. The company has a quick ratio of 0.52, a current ratio of 0.69 and a debt-to-equity ratio of 0.38. Haleon PLC Sponsored ADR has a 12-month low of $8.65 and a 12-month high of $11.28. The company has a market cap of $40.62 billion, a P/E ratio of 23.68, a price-to-earnings-growth ratio of 2.09 and a beta of 0.12.

Haleon Cuts Dividend

The firm also recently declared a dividend, which will be paid on Thursday, September 17th. Stockholders of record on Friday, August 14th will be issued a dividend of $0.0642 per share. The ex-dividend date is Friday, August 14th. This represents a dividend yield of 132.0%. Haleon's payout ratio is currently 30.77%.

About Haleon

Haleon plc NYSE: HLN is a global consumer healthcare company that develops, manufactures and markets products for everyday health and wellness needs. Its portfolio spans oral health, pain relief, respiratory health, vitamins and supplements, digestive health, and therapeutic skin care.

Haleon's well-known brands include Sensodyne, Polident, parodontax, Voltaren, Panadol, Advil, Centrum, Emergen-C, Theraflu, Otrivin, Calpol, ChapStick and Excedrin. The company sells its products through pharmacies, supermarkets, mass retailers, e-commerce platforms and other healthcare channels.

Haleon was formed through the demerger of GSK's consumer healthcare business and became an independent company in 2022.

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon PLC Sponsored ADR (NYSE:HLN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.